UT-MD Anderson Cancer Center: Genetic Marker Linked to Improved Survival With Immunotherapy in Ovarian and Other Cancers
July 03, 2025
July 03, 2025
HOUSTON, Texas, July 3 (TNSjou) -- The University of Texas MD Anderson Cancer Center issued the following news release:
* * *
New genetic marker linked to improved survival with immunotherapy in ovarian and other cancers
* Ovarian clear cell carcinoma is difficult to treat, and treatment options are limited
* Patients with specific PPP2R1A mutations in their tumors survived significantly longer after immunotherapy treatment
* Targe . . .
* * *
New genetic marker linked to improved survival with immunotherapy in ovarian and other cancers
* Ovarian clear cell carcinoma is difficult to treat, and treatment options are limited
* Patients with specific PPP2R1A mutations in their tumors survived significantly longer after immunotherapy treatment
* Targe . . .